About
Marco Demaria is a Dutch-based aging-biology scientist focused on cellular senescence, longevity therapeutics, and age-related pathology. He is Professor of Cellular Ageing and Senescence at the University Medical Center Groningen, Director of MoHAD, and group leader at ERIBA. He also co-founded Cleara Biotech and holds visible ecosystem roles including Editor-in-Chief of Aging-US and President of the International Cell Senescence Association.
Areas of interest
longevityaging biologycellular senescencebiotechsenotherapeuticscancermetastasischemotherapy toxicitybiomarkersskin biologywound healingtranslational medicine